M V Relling

Higher frequency of glutathione S-transferase deletions in black children with acute lymphoblastic leukemia.

M. Relling, C. Pui, W. Evans, 1997, Blood.

Genome-wide approach to identify risk factors for therapy-related myeloid leukemia

M. Relling, C. Pui, A. Bogni, 2006, Leukemia.

Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing: 2013 Update

T E Klein, M Schwab, M. Relling, 2013, Clinical pharmacology and therapeutics.

Treatment-specific changes in gene expression discriminate in vivo drug response in human leukemia cells

J. Downing, M. Relling, C. Pui, 2003, Nature Genetics.

Altered expression of hepatic cytochromes P-450 in mice deficient in one or more mdr1 genes.

M. Relling, L. Nguyen, E. Schuetz, 2000, Molecular pharmacology.

Saturable pharmacokinetics and paclitaxel pharmacodynamics in children with solid tumors.

J J Shuster, M. Relling, J. Shuster, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The Pharmacogenetics Research Network: From SNP Discovery to Clinical Drug Response

R B Altman, D M Roden, H L McLeod, 2007, Clinical pharmacology and therapeutics.

Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing

T E Klein, M. Relling, C. Pui, 2011, Clinical pharmacology and therapy.